Search research articles
Contact Us
Filters
Showing results (171-180 of 381) with videos related to
Page
of 39
Sort By:
Respiratory Medicine
|
April 13, 2011
Clonality and phenotyping analysis of alveolar lymphocytes is suggestive of pulmonary MALT lymphoma
Raphael Borie, Marie Wislez, Martine Antoine, et al.
ACR Open Rheumatology
|
July 19, 2022
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
Shervin Assassi, Oliver Distler, Yannick Allanore, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 6, 2016
Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF
Simone Ebener, Sandra Barnowski, Carlos Wotzkow, et al.
Joint Bone Spine
|
September 24, 2016
Cystic lung disease in Sjögren's syndrome: An observational study
Sarah Lechtman, Marie-Pierre Debray, Bruno Crestani, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 24, 2013
Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia
Stephane Gaudry, François Vincent, Antoine Rabbat, et al.
International Journal of Cardiology
|
December 12, 2018
Treatment of cardiac sarcoidosis: A comparative study of steroids and steroids plus immunosuppressive drugs
Thomas Ballul, Raphael Borie, Bruno Crestani, et al.
Rheumatology (Oxford, England)
|
December 10, 2021
Salivary gland ultrasonography in patients with connective tissue diseases: a multi-centre observational study
Manon Lesturgie-Talarek, Julia Goossens, Sabryne Berkani, et al.
The European Respiratory Journal
|
June 20, 2020
Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection
Justine Frija-Masson, Marie-Pierre Debray, Marie Gilbert, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 5, 2024
FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis
Mada Ghanem, Gabrielle Archer, Aurélien Justet, et al.
Thorax
|
October 11, 2017
Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension
Luca Richeldi, Michael Kreuter, Moisés Selman, et al.
Page
of 39
Search research articles
Search
Showing results (171-180 of 381) with videos related to
Sort By:
Page
of 39
Respiratory Medicine
|
April 13, 2011
Clonality and phenotyping analysis of alveolar lymphocytes is suggestive of pulmonary MALT lymphoma
Raphael Borie, Marie Wislez, Martine Antoine, et al.
ACR Open Rheumatology
|
July 19, 2022
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
Shervin Assassi, Oliver Distler, Yannick Allanore, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 6, 2016
Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF
Simone Ebener, Sandra Barnowski, Carlos Wotzkow, et al.
Joint Bone Spine
|
September 24, 2016
Cystic lung disease in Sjögren's syndrome: An observational study
Sarah Lechtman, Marie-Pierre Debray, Bruno Crestani, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 24, 2013
Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia
Stephane Gaudry, François Vincent, Antoine Rabbat, et al.
International Journal of Cardiology
|
December 12, 2018
Treatment of cardiac sarcoidosis: A comparative study of steroids and steroids plus immunosuppressive drugs
Thomas Ballul, Raphael Borie, Bruno Crestani, et al.
Rheumatology (Oxford, England)
|
December 10, 2021
Salivary gland ultrasonography in patients with connective tissue diseases: a multi-centre observational study
Manon Lesturgie-Talarek, Julia Goossens, Sabryne Berkani, et al.
The European Respiratory Journal
|
June 20, 2020
Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection
Justine Frija-Masson, Marie-Pierre Debray, Marie Gilbert, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 5, 2024
FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis
Mada Ghanem, Gabrielle Archer, Aurélien Justet, et al.
Thorax
|
October 11, 2017
Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension
Luca Richeldi, Michael Kreuter, Moisés Selman, et al.
Page
of 39